Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bridging rapid and sustained antidepressant effects of ketamine
Ji‐Woon Kim, Kanzo Suzuki, Ege T. Kavalali, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 5, pp. 364-375
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Ketamine: Mechanisms and Relevance to Treatment of Depression
Ji‐Woon Kim, Kanzo Suzuki, Ege T. Kavalali, et al.
Annual Review of Medicine (2023) Vol. 75, Iss. 1, pp. 129-143
Closed Access | Times Cited: 51
Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments
John H. Krystal, Alfred P. Kaye, Sarah Jefferson, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 49
Open Access | Times Cited: 30
Beyond the serotonin deficit hypothesis: communicating a neuroplasticity framework of major depressive disorder
Chloe E. Page, C. Neill Epperson, Andrew M. Novick, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 12, pp. 3802-3813
Closed Access | Times Cited: 11
Transcriptional signatures of early-life stress and antidepressant treatment efficacy
Sero Toriano Parel, Shannon N. Bennett, C. Cheng, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 49
Open Access | Times Cited: 13
Identifying compounds to treat opiate use disorder by leveraging multi-omic data integration and multiple drug repurposing databases
Jeran K. Stratford, Megan U. Carnes, Caryn Willis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
The role of mGluR5 on the therapeutic effects of ketamine in Wistar rats
Dilan Gokalp, Güneş Ünal
Psychopharmacology (2024) Vol. 241, Iss. 7, pp. 1399-1415
Open Access | Times Cited: 4
Subanesthetic Ketamine Ameliorates Activity‐Based Anorexia of Adult Mice
Yiru Dong, Chiye Aoki
Synapse (2025) Vol. 79, Iss. 1
Closed Access
Demystifying the Antidepressant Mechanism of Action of Stinels, a Novel Class of Neuroplastogens: Positive Allosteric Modulators of the NMDA Receptor
John E. Donello, Roger S. McIntyre, Donald B. Pickel, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 157-157
Open Access
Brain-derived neurotrophic factor (BDNF) changes in rodent models of schizophrenia induced by ketamine: a systematic review
Atefeh Motamedi-Manesh, Mahdieh Farzin Asanjan, Hamed Fallah, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Preclinical Behavioral and Pharmacological Treatments for Enhancing Fear Extinction in Adolescence
Emily K. Wall, Elizabeth A Virakorn, Kathryn Baker, et al.
Neuroscience & Biobehavioral Reviews (2025), pp. 106090-106090
Open Access
Rapid hippocampal synaptic potentiation induced by ketamine metabolite (2R,6R)-hydroxynorketamine persistently primes synaptic plasticity
Kyle A. Brown, Musa Iyiola Ajibola, Todd D. Gould
Neuropsychopharmacology (2025)
Open Access
Ketamine rescues anhedonia by cell-type- and input-specific adaptations in the nucleus accumbens
Federica Lucantonio, Jacob Roeglin, Shuwen Li, et al.
Neuron (2025)
Open Access
Targeting HINT1 to improve synaptic plasticity: toward loganin as a new antidepressant strategy
Cong‐Yuan Xia, Guo-Yan Zuo, Manni Wang, et al.
Molecular Psychiatry (2025)
Closed Access
Mechanisms of SSRI Therapy and Discontinuation
Trevor Sharp, Helen Collins
Current topics in behavioral neurosciences (2023), pp. 21-47
Closed Access | Times Cited: 11
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents
Adam K. Klein, Eric W. Austin, Michael J. Cunningham, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 6, pp. 905-914
Open Access | Times Cited: 3
New perspective on sustained antidepressant effect: focus on neurexins regulating synaptic plasticity
Yuan Ruan, Ruolan Yuan, Jiaqi He, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Functional and Molecular Changes in the Prefrontal Cortex of the Chronic Mild Stress Rat Model of Depression and Modulation by Acute Ketamine
Jessica Mingardi, Elona Ndoj, Tiziana Bonifacino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10814-10814
Open Access | Times Cited: 7
Locus Coeruleus‐Dorsolateral Septum Projections Modulate Depression‐Like Behaviors via BDNF But Not Norepinephrine
Qian Zhang, You Xue, Wei Ke, et al.
Advanced Science (2023) Vol. 11, Iss. 10
Open Access | Times Cited: 7
Distinct synaptic mechanisms drive the behavioral response to acute stress and rapid correction by ketamine
Ji‐Woon Kim, Benjamin Kleinfelter, Ege T. Kavalali, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 12, pp. 1916-1924
Open Access | Times Cited: 2
Neuron‐Derived Extracellular Vesicles miRNA Profiles Identify Children Who Experience Adverse Events after Ketamine Administration for Procedural Sedation
Marianna Lucafò, Carlotta Bidoli, Martina Franzin, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 117, Iss. 1, pp. 174-183
Open Access | Times Cited: 2
Temporal dynamics of BDNF signaling recruitment in the rat prefrontal cortex and hippocampus following a single infusion of a translational dose of ketamine
Lucia Caffino, Francesca Mottarlini, Alessandro Piva, et al.
Neuropharmacology (2023) Vol. 242, pp. 109767-109767
Open Access | Times Cited: 5
Ketamine and electroconvulsive therapy for severe depression: A network meta-analysis of efficacy and safety
Yecun Liu, Jiguo Yang, Yuanxiang Liu
Journal of Psychiatric Research (2024) Vol. 175, pp. 218-226
Closed Access | Times Cited: 1
Enduring modulation of dorsal raphe nuclei regulates (R,S)-ketamine-mediated resilient stress-coping behavior
Anderson Camargo, Anna Nilsson, Mohammadreza Shariatgorji, et al.
Molecular Psychiatry (2024)
Open Access | Times Cited: 1
Depression-like effects induced by chronic unpredictable mild stress in mice are rapidly reversed by a partial negative allosteric modulator of mGlu5 receptor, M-5MPEP
Agnieszka Pałucha-Poniewiera, Bartosz Bobula, Anna Rafało-Ulińska, et al.
Psychopharmacology (2024)
Open Access | Times Cited: 1
Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review
Simone Pardossi, Andrea Fagiolini, Alessandro Cuomo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13098-13098
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top